Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related PhenotypesSang‐Hyuk Jung, Hong‐Hee Won, Soo Jin Yoon et al.|JAMA Network Open|2022Cited by 47
Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trialSeong‐Ho Koh, Kyu‐Yong Lee, Hyuk Sung Kwon et al.|Alzheimer s Research & Therapy|2021Cited by 38
A Two-Year Observational Study to Evaluate Conversion Rates from High- and Low-Risk Patients with Amnestic Mild Cognitive Impairment to Probable Alzheimer’s Disease in a Real-World SettingHyemin Jang, Mee Young Park, Duk L. Na et al.|Journal of Alzheimer s Disease Reports|2024Cited by 5
Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: <i>Post Hoc</i> Analysis of Severe Impairment Battery SubscalesHyuk Sung Kwon, Sangjae Kim, Seong‐Ho Koh et al.|Dementia and Neurocognitive Disorders|2023Cited by 4